mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.7 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.7 |